Insiders · SGTX

SGTX insider transactions

Sigilon Therapeutics Inc. (SGTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for SGTX

• 1028d
  SEC Form 4 filed by Flagship Ventures Fund V General Partner Llc

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1029d
  SEC Form 4: Eli Lilly & Co bought $25,639,916 worth of shares (1,718,493 units at $14.92)

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1032d
  SEC Form 4 filed by Oesterle Stephen N.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1032d
  SEC Form 4 filed by Cole Douglas G.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1032d
  SEC Form 4: Cox John returned 341 shares to the company, closing all direct ownership in the company

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1032d
  SEC Form 4 filed by Shaff Eric D.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1032d
  SEC Form 4: Yuan Qing Sarah returned 2,884 shares to the company, closing all direct ownership in the company

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1032d
  SEC Form 4: Kowalsky Matthew Paul returned 1,925 shares to the company, closing all direct ownership in the company

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1032d
  SEC Form 4 filed by Ashton-Rickardt Philip

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1032d
  SEC Form 4 filed by Patel Kavita

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1032d
  SEC Form 4 filed by Ruffolo Robert R

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1032d
  SEC Form 4: Vivaldi Coelho Rogerio returned 12,169 shares to the company, closing all direct ownership in the company

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1032d
  SEC Form 4: Pontes Josias returned 3,504 shares to the company, closing all direct ownership in the company

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1047d
  SEC Form 4 filed by Yuan Qing Sarah

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1050d
  SEC Form 4 filed by Pontes Josias

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1050d
  SEC Form 4 filed by Vivaldi Coelho Rogerio

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1067d
  SEC Form 3: New insider Eli Lilly & Co claimed ownership of 211,110 shares

  3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1113d
  SEC Form 4 filed by Oesterle Stephen N.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1113d
  SEC Form 4 filed by Ruffolo Robert R

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1113d
  SEC Form 4 filed by Shaff Eric D.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1113d
  SEC Form 4 filed by Cox John

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1113d
  SEC Form 4 filed by Patel Kavita

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1113d
  SEC Form 4 filed by Cole Douglas G.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1195d
  SEC Form 4 filed by Kowalsky Matthew Paul

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1195d
  SEC Form 4 filed by Vivaldi Coelho Rogerio

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1195d
  SEC Form 4 filed by Pontes Josias

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1195d
  SEC Form 4 filed by Ashton-Rickardt Philip

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1195d
  SEC Form 4 filed by Yuan Qing Sarah

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1195d
  SEC Form 3: New insider Kowalsky Matthew Paul claimed ownership of 19,683 shares

  3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1473d
  SEC Form 4 filed by Story Brooke

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1473d
  SEC Form 4 filed by Patel Kavita

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1473d
  SEC Form 4 filed by Oesterle Stephen N.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1473d
  SEC Form 4 filed by Shaff Eric D.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1473d
  SEC Form 4 filed by Ruffolo Robert R

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1526d
  SEC Form 4 filed by Yuan Qing Sarah

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1551d
  SEC Form 3 filed by new insider Yuan Qing Sarah

  3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1567d
  SEC Form 4 filed by Ashton-Rickardt Philip

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1567d
  SEC Form 4 filed by Vivaldi Coelho Rogerio

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1567d
  SEC Form 4 filed by Pontes Josias

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1567d
  SEC Form 4 filed by Orfali May

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1616d
  SEC Form 4 filed by Ashton-Rickardt Philip

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1616d
  SEC Form 4 filed by Orfali May

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1616d
  SEC Form 4 filed by Vivaldi Coelho Rogerio

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1616d
  SEC Form 4 filed by Pontes Josias

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1650d
  SEC Form 4 filed by Orfali May

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1650d
  SEC Form 3 filed by new insider Orfali May

  3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1676d
  SEC Form 4: Vivaldi Coelho Rogerio was granted 50,000 shares, increasing direct ownership by 213% to 73,461 units

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1708d
  SEC Form 4: Pontes Josias was granted 11,500 shares, increasing direct ownership by 625% to 13,339 units

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1802d
  SEC Form 4: RUFFOLO ROBERT R exercised 6,750 units of Common Stock at a strike of $0.57 and sold $69,930 worth of Common Stock (6,750 units at $10.36)

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1807d
  SEC Form 4 filed by Cole Douglas G.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1807d
  SEC Form 4 filed by Shaff Eric D.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1807d
  SEC Form 4 filed by Cox John

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1807d
  SEC Form 4 filed by Patel Kavita

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1807d
  SEC Form 4 filed by RUFFOLO ROBERT R

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1807d
  SEC Form 4 filed by Oesterle Stephen N.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1813d
  SEC Form 3: Pontes Josias claimed ownership of 600 units of Common Stock

  3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1818d
  SEC Form 4 filed by Story Brooke

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1818d
  SEC Form 3 filed by Story Brooke

  3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1820d
  SEC Form 3 filed by Ashton-Rickardt Philip

  3 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1830d
  SEC Form 4: ANDERSON DANIEL GRIFFITH sold $2,000,000 worth of Common Stock (200,000 units at $10.00), decreasing direct ownership by 9% to 2,022,222 units

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)